Natrixam (Indapamide, Amlodipine Besilate)

Indapamide reduces plasma volume by inhibiting sodium‑chloride reabsorption in the kidney, while amlodipine relaxes arterial smooth muscle by blocking L‑type calcium channels. Together they decrease vascular resistance and fluid volume, resulting in a complementary antihypertensive effect.

The appropriate dose of Natrixam is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any concomitant medications. Dosage adjustments are made according to individual needs.

Safety of Natrixam in pregnancy or while breastfeeding has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent therapy, Natrixam offers dual mechanisms—diuresis and vasodilation—in a single tablet, which can improve blood pressure control and simplify dosing. It may be preferred over separate prescriptions when a combined effect is desired.

Natrixam tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Natrixam is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water and follow any specific instructions provided by the healthcare professional.

Serious risks include severe hypotension, electrolyte imbalances such as hyponatremia or hypokalemia, angioedema, and rare cases of hepatic dysfunction or anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like swelling of the face or throat, severe dizziness, or unusual fatigue.

Natrixam is contraindicated in patients with known hypersensitivity to indapamide, amlodipine, or any component of the formulation. It should also be avoided in individuals with severe renal impairment, uncontrolled heart failure, or those taking interacting medications that could cause dangerous blood pressure drops.